About Rohto Group
Rohto Group is a publicly listed company based in Osaka (Japan) founded in 1899. Pharmaceuticals and healthcare products are developed for global well-being. The company has 9,140 employees. Rohto Group has completed 1 acquisition, including Eu Yan Sang. Its website rohto.co.jp draws about 1.2 million monthly visits. Rohto Group offers products and services including Eye Care Products and Skincare Products. Its focus areas include Traditional Pharmaceuticals. Its legal entity is Rohto Pharmaceutical Co., Ltd.
Company details
The company was founded in 1899 in Osaka, Japan, and operates within the pharmaceuticals and healthcare sector. A diverse portfolio of products, including pharmaceuticals and skincare items, is offered. Research and development efforts are prioritized to produce innovative healthcare solutions. Operations are conducted with a focus on sustainability and social responsibility across international markets. Global contributions to health improvements are pursued through these activities.
- Headquarters Osaka, Japan
- Employees 9,140
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website rohto.co.jp
- Social LinkedIn X Facebook Instagram
- Legal Name Rohto Pharmaceutical Co., Ltd.
- Annual Revenue$2.16 B (USD)11.37as on Mar 31, 2026
- Net Profit$214.74 M (USD)11.05as on Mar 31, 2026
- EBITDA$364.14 M (USD)13.75as on Mar 31, 2026
- Employee Count9,140
- Investments & Acquisitions
Products & Services of Rohto Group
Rohto Group offers a comprehensive portfolio of products and services, including Eye Care Products and Skincare Products.
Eye care products are manufactured and distributed to address health maintenance needs.
Skincare products are developed and offered to support beauty and wellness applications.
People of Rohto Group
9 people are tracked at Rohto Group (5 in leadership, 4 in team); the tracked headcount is 9,140.
| Name | Role | Group |
|---|---|---|
Kunio Yamada | Chairman and Chief Executive Officer | Leadership |
Itsuko Yamada | Chief Strategic Designer | Leadership |
Noriko Oki Masuda | Director, International Partnerships | Leadership |
Mario Novaes | Head Of Marketing And Sales | Leadership |
Koji Suzuki | Head Of International Business | Leadership |
Zain Attar | Senior Medical Representative | Team |
Prodip Das | International Business | Team |
Sindhu Thangavel | Business Development Specialist | Team |
Satoko Fujishima | Project Leader | Team |
Complete people profiles for Rohto Group
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Rohto Group
Rohto Group is a publicly listed company on the TSE with ticker symbol 4527 in Japan, operating in the Consumer non-durables sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date15 Oct 1962
- Listed onTSE: 4527
- Listed entityRohto Pharmaceutical Co., Ltd.
- Exchange sectorConsumer non-durables
- ISINJP3982400008
- Share price2,830.00 JPY (+1.22% on the day) · 2026-10-14
- Market capitalisation649,117,194,397.00 JPY
- Price to earnings20.2
- EPS (diluted, trailing year)140.40 JPY
- Dividend yield1.86%
- Volume (last session)1,296,800
Financials of Rohto Group
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 343.73B JPY | 34.25B JPY | 58.08B JPY |
| 2024 | 308.63B JPY | 30.84B JPY | 51.06B JPY |
| 2023 | 270.84B JPY | 30.94B JPY | 48.85B JPY |
| 2022 | 238.66B JPY | 26.38B JPY | 41.34B JPY |
| 2021 | 199.65B JPY | 21.13B JPY | 35.55B JPY |
Detailed financial statements for Rohto Group
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Rohto Group
Rohto Group has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Eu Yan Sang.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Traditional Chinese Medicine products and services are retailed and provided. | euyansang.com | Singapore | 1879 | Apr 2024 | $508.72M |
Complete acquisition details for Rohto Group
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Rohto Group
3 dated milestones of Rohto Group across 125 years, from founding to its latest funding, stage changes and deals.
- Founded Rohto Group is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Eu Yan Sang.
Web traffic of Rohto Group
The website of Rohto Group (rohto.co.jp) receives about 1.2M visits a month and ranks #61,757 among all websites worldwide, #1,672 in Biotechnology and Pharmaceuticals.
- Monthly visits1.2M
▲ 28% vs previous month
- Unique visitors589.4K
per month
- Global rank#61,757
among all websites
- Category rank#1,672
Health · Biotechnology and Pharmaceuticals
- Bounce rate51%
- Pages per visit2.3
- Average visit1 min 12 sec
- DevicesDesktop 20% · Mobile 80%
Websites whose visitors overlap most with Rohto Group. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| chugai-pharm.co.jp | 100% | 180.8K | #220,597 | View details | |
| taiho.co.jp | 86% | #293,478 | View details | ||
mizumushi-navi.com | mizumushi-navi.com | 85% | – | ||
koko-clinic.com | koko-clinic.com | 83% | #1,873,325 | – | |
novartis.co.jp | novartis.co.jp | 82% | #481,574 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Rohto Group
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Rohto Group
Complete news archive for Rohto Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rohto Group
Rohto Group was founded in 1899.
Rohto Group is headquartered in Osaka, Japan. It is registered at Osaka, Osaka Prefecture, Japan.
Rohto Group has 9,140 employees.
Annual revenue of Rohto Group is $2.16B as on Mar 31, 2026.
The company was founded in 1899 in Osaka, Japan, and operates within the pharmaceuticals and healthcare sector. A diverse portfolio of products, including pharmaceuticals and skincare items, is offered. Research and development efforts are prioritized to produce innovative healthcare solutions. Operations are conducted with a focus on sustainability and social responsibility across international markets. Global contributions to health improvements are pursued through these activities.
Rohto Group offers Eye Care Products and Skincare Products.
Yes, Rohto Group is publicly traded on TSE under the ticker symbol 4527.
Rohto Group has made 1 acquisition, including Eu Yan Sang.
Rohto Group operates through Rohto Pharmaceutical Co., Ltd..
The website of Rohto Group receives about 1.2 million visits a month and ranks #61,757 among all websites worldwide.